Stocks
Arrowhead Pharmaceuticals (ARWR) P/E US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| P/E | ? | 38.9 | -51.3 | -46.0 | -19.7 | -14.0 | -6.03 | ||
| Changes by years, y/y, % | -232% | -232% | -10% | -57% | -29% | -13.8% | |||
Arrowhead Pharmaceuticals. P/E
Arrowhead Pharmaceuticals. P/E, changes, %
Arrowhead Pharmaceuticals (ARWR) P/E US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| P/E | ? | -21.0 | -14.0 | -11.1 | -7.49 | -5.99 | -6.03 | |
| Changes by years, y/y, % | -15% | -31% | -61% | -58% | -71% | |||
| Changes by quarters, q/q, % | +16% | -33% | -21% | -32% | -20% | |||
